New Drug Formulation Shows Promise in Preventing Corneal Blindness in India

Corneal blindness, a significant public health issue in India affecting millions with scarring and vision loss, is often detected too late for effective early-stage therapy. Currently, patients typically require corneal transplants, but the demand for donated corneas far exceeds supply. A new development involves a repurposed blood pressure drug, losartan, showing potential as the world's first ophthalmic formulation to manage corneal wound scarring, offering a possible preventative treatment for this condition.